Coverage of a new PCSK9 trial makes bold claims about prevention and risk reduction. But how well do they hold up to scrutiny ...

With 38% of U.S. adults living with high cholesterol, experts say understanding how statins work — and whether you need them ...

Currently available therapies such as niacin and PCSK9 inhibitors such as Repatha (evolocumab) and Praluent (alirocumab) can reduce Lp (a) levels, but their impact is modest. Another challenge in ...

Pharmaceutical company Boehringer Ingelheim said on Monday the U.S. Food and Drug Administration had approved its chewable ...

Generic statins and angiotensin receptor blockers typically used for heart disease also have the potential to bolster the immune systems of patients with Ebola virus and other life-threatening ...

More than a decade ago, GLP-1 drugs began being marketed for weight loss. Sexenda was approved in the U.S. in 2014, and ...

The American College of Cardiology found uneven gains and sobering declines in heart health. "You can't treat your way out of ...

Common OTC painkillers like ibuprofen may increase heart attack and stroke risk. Learn which medications pose the greatest ...

With better access to tools like CCTA and diagnostic tools that leverage CCTA, clinicians can better support their patients in managing overall cardiovascular health, patients will benefit from less ...

Millions of people live with atrial fibrillation, a racing, uneven heartbeat that can leave you exhausted and scared. Yet it ...

Women’s cardiovascular health has long been overlooked and understudied. Here are some things to keep in mind.